Bank Of America Corp Forte Biosciences, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Forte Biosciences, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 265 shares of FBRX stock, worth $1,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares

265

Holding current value

$1,240

% of portfolio

0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.46 - $0.78 $121 - $206	265 New	265 $0
Q4 2023 Feb 14, 2024	SELL	$0.38 - $0.82 $36 - $78	-96 Reduced 82.05%	21 $0
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.11 $237 - $268	-242 Reduced 67.41%	117 $0
Q1 2023 May 12, 2023	BUY	$0.98 - $1.06 $192 - $207	196 Added 120.25%	359 $0
Q4 2022 Feb 10, 2023	SELL	$0.96 - $28.0 $75 - $2,212	-79 Reduced 32.64%	163 $0
Q3 2022 Nov 14, 2022	SELL	$1.06 - $27.75 $1,303 - $34,132	-1,230 Reduced 83.56%	242 $0
Q2 2022 Aug 12, 2022	SELL	$1.07 - $1.55 $63,489 - $91,970	-59,336 Reduced 97.58%	1,472 $1,000
Q1 2022 May 16, 2022	SELL	$1.21 - $2.24 $2,787 - $5,160	-2,304 Reduced 3.65%	60,808 $89,000
Q4 2021 Feb 08, 2022	BUY	$2.02 - $3.36 $114,594 - $190,612	56,730 Added 888.91%	63,112 $136,000
Q3 2021 Nov 15, 2021	BUY	$2.96 - $36.67 $5,644 - $69,929	1,907 Added 42.61%	6,382 $19,000
Q2 2021 Sep 13, 2021	BUY	$31.5 - $42.5 $140,962 - $190,187	4,475 New	4,475 $150,000

Others Institutions Holding FBRX

# of Institutions

Shares Held

17.3M

Call Options Held

3.1K

Put Options Held

Tybourne Capital Management (Hk) LTD Hong Kong, K3

3.62M
Shares

$17 Million
0.49% of portfolio
Perceptive Advisors LLC New York, NY

3.27M
Shares

$15.3 Million
0.05% of portfolio
Bvf Inc San Francisco, CA

2.98M
Shares

$14 Million
0.05% of portfolio
Cable Car Capital LLC San Francisco, CA

2.03M
Shares

$9.51 Million
1.15% of portfolio
Fred Alger Management, LLC New York, NY

1.84M
Shares

$8.61 Million
0.0% of portfolio

View Full List

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $95.2M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account